Ann: AnteoTech Developing Multiplex Test for COVID-19, page-366

First 366 Last

Share
Profile

Follow
slippin

8,217 Posts.

1151

19/07/20

10:42

Post #: 45962382
Share

Originally posted by captainblood ↑

from the announcement.

"High sensitivity and increased detection enabled by the AnteoBind Europium particle conjugation. This allows earlier detection of the disease and the potential for detection from saliva as well as mucus samples. As AnteoTech hold the IP for AnteoBind and has not licensed AnteoBind activated Europium particles for COVID-19 antigen assays, no other COVID-19 test on the market has or will have AnteoBind activated Europium as a basis for COVID-19 testing in the foreseeable future."

seeing that the Merck announcement was

AnteoTech Ltd is pleased to announce that it has signed a non-binding Heads of Agreement with Merck to co-develop AnteoBind activated Europium particles for the rapidly growing global point of care (PoC) diagnostic testing market.

so if Merck was to release our co-developed Anteobind activated Europium particles, how could we claim that they wouldn't be used in other tests? the Merck HOA was suppose to commercialised in the last quarter but still no word. the deal hasn't fallen thru with evidence of Merck's using Charlie in their presentations

so it appears that instead of supplying our Europium particles to be used in the rapidly growing global POC diagnostic testing market, we may just be keeping them for ourself and producing our own sepsis multiplex test and covid multiplex tests and ???

it's been over 4 month since the HOA was announced, what could the next Merck ann be?

Expand

What?

ADO Price at posting: 3.2¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk